FRUZAQLA

This brand name is authorized in Austria, France, Lithuania, Romania, United States

Active ingredients

The drug FRUZAQLA contains one active pharmaceutical ingredient (API):

1 Fruquintinib
UNII 49DXG3M5ZW - FRUQUINTINIB

Fruquintinib is a selective tyrosine kinase inhibitor of VEGFR-1, -2, and -3 with antitumor effects resulting from suppression of tumour angiogenesis.

Read about Fruquintinib

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
FRUZAQLA Hard capsule European Medicines Agency (EU) MPI, EU: SmPC
FRUZAQLA Hard capsule FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01EK04 L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
Discover more medicines within L01EK04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: FR Base de données publique des médicaments Identifier(s): 63200612, 64771069
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1100271, 1100272
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W70451001, W70452001
Country: US FDA, National Drug Code Identifier(s): 63020-210, 63020-225

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.